Abstract
Current in vivo angiogenesis assays allow for the assessment of vascular growth inhibition induced by a test substance, but they usually do not provide information about the mechanisms underlying such an inhibition. A potential antiangiogenic mechanism is the triggering of endothelial apoptosis in the growing vessels. Apoptogenic substances can be of interest for antiangiogenic therapy specially if they specifically perform their action on the angiogenic endothelium. We have developed a modification of the chorioallantoic membrane (CAM) assay using embryos of quail (Coturnix coturnix japonica). This novel assay allows to elucidate whether an antiangiogenic substance is specifically triggering an apoptotic response in endothelial cells. We have used a quail-specific monoclonal endothelial marker (QH1), a standard TUNEL technique of apoptotic cell labelling together with a general nuclear counterstaining with propidium iodide. Through laser confocal microscopy, paraffin sections of chorioallantoic membranes treated with test substances are stained in three colours: red for normal cell nuclei, yellow—green for apoptotic nuclei and blue for endothelial cells and endothelial progenitors. In a test experience, our assay showed significant differences in the apoptogenic properties of two antiangiogenic substances, camptothecin and aeroplysinin-1.
References
Folkman J. Angiogenesis in cancer, vascular rheumatoid and other disease. Nat Med 1995; 1: 27–31.
Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nature Rev Cancer 2002; 2: 727–39.
Jain RK, Schlenger K, Höckel M, Yuan F. Quantitative angiogenesis assays: Progress and problems. Nat Med 1997; 3: 1203–8.
Auerbach R, Lewis R, Shinners B et al. Angiogenesis assays: A critical overview. Clin Chem 2003; 49: 32–40.
Parsons-Wingerter P, Lwai B, Yang MC et al. A novel assay of angiogenesis in the quail chorioallantoic membrane: Stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res 1998; 55: 201–14.
Oh SJ, Jeltsch MM, Birkenhager R et al. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. De Biol 1997; 188: 96–109.
Pardanaud L, Altmann C, Kitos P et al. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development 1987; 100: 339–49.
Kollmannsberger C, Mross K, Jakob A et al. Topotecan – A novel topoisomerase I inhibitor: Pharmacology and clinical experience. Oncology 1999; 56(1): 1–12.
Kaufmann SH. Cell death induced by topoisomerase-targeted drugs: More questions than answers. Biochim Biophys Acta 1998; 1400: 195–211.
Jung LL, Zamboni WC. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: Can we improve it? Drug Resist Update 2001; 4: 273–88.
Clements MK, Jones CB, Cumming M, Daoud SS. Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol 1999; 44: 411–6.
Xiao D, Tan W, Li M, Ding J. Antiangiogenic potential of 10-hydroxycamptothecin. Life Sci 2001; 69: 1619–28.
Nakashio A, Fujita N, Tsuruo T. Topotecan inhibits VEGF and bFGF induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway. Int J Cancer 2002; 98: 36–41.
Rodríguez-Nieto S, González-Iriarte M, Carmona R et al. Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J 2002; 16: 261–3.
Kreuter MH, Leake RE, Rinaldi F et al. Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1. Comp Biochem Physiol 1990; 97: 151–8.
Ribatti D, Urbinati C, Nico B et al. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Biol 1995; 170: 39–49.
Kreuter MH, Bernd A, Holzmann H et al. Cytostatic activity of aeroplysinin-1 against lymphoma and epithelioma cells. Z Naturforsch [C] 1989; 44(7–8): 680–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
González-Iriarte, M., Carmona, R., Pérez-Pomares, J.M. et al. A Modified Chorioallantoic Membrane Assay Allows for Specific Detection of Endothelial Apoptosis Induced by Antiangiogenic Substances. Angiogenesis 6, 251–254 (2003). https://doi.org/10.1023/B:AGEN.0000021388.59617.6b
Issue Date:
DOI: https://doi.org/10.1023/B:AGEN.0000021388.59617.6b